Luc Grislain

Title: Luc Grislain: Innovator in Pharmaceutical Dosage Units

Introduction

Luc Grislain is a notable inventor based in Blanquefort, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of dosage units for rectal administration. His innovative approach has the potential to enhance the effectiveness of pharmaceutical treatments.

Latest Patents

Grislain holds a patent for a pharmaceutical dosage unit designed for rectal administration. This dosage unit is characterized by a sheath made of a bioadhesive material that encases one or more capsules along with non-liquid supports containing the active pharmaceutical ingredient. The capsules consist of a mixture of approximately 70% gelatin and 30% glycerin. The non-liquid supports can be in the form of tablets. This dosage unit is particularly useful for providing a sustained release effect of the pharmaceutical ingredient in the lower part of the rectum for a duration of 24 hours. He has 1 patent to his name.

Career Highlights

Throughout his career, Luc Grislain has worked with several prominent companies in the pharmaceutical industry. Notable among these are Asta Medica and Concept, Inc. His work has contributed to advancements in pharmaceutical formulations and delivery systems.

Collaborations

Grislain has collaborated with various professionals in his field, including Elisabeth Le Huede and Olivier Louis. These collaborations have likely enriched his work and contributed to the success of his innovations.

Conclusion

Luc Grislain's contributions to the pharmaceutical industry, particularly through his innovative dosage unit for rectal administration, highlight his role as a significant inventor. His work continues to influence the development of effective pharmaceutical treatments.